BioSig Technologies (BSGM) Competitors $0.92 +0.10 (+12.13%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$0.95 +0.03 (+3.14%) As of 02/21/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends BSGM vs. APT, TMDIF, CTSO, APYX, INO, MODD, NXL, MBOT, BLAC, and OMShould you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include Alpha Pro Tech (APT), Titan Medical (TMDIF), Cytosorbents (CTSO), Apyx Medical (APYX), Inovio Pharmaceuticals (INO), Modular Medical (MODD), Nexalin Technology (NXL), Microbot Medical (MBOT), Bellevue Life Sciences Acquisition (BLAC), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. BioSig Technologies vs. Alpha Pro Tech Titan Medical Cytosorbents Apyx Medical Inovio Pharmaceuticals Modular Medical Nexalin Technology Microbot Medical Bellevue Life Sciences Acquisition Outset Medical BioSig Technologies (NASDAQ:BSGM) and Alpha Pro Tech (NYSE:APT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, community ranking, analyst recommendations and risk. Which has preferable earnings and valuation, BSGM or APT? Alpha Pro Tech has higher revenue and earnings than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioSig Technologies$20K797.35-$29.04MN/AN/AAlpha Pro Tech$61.23M1.01$4.19M$0.3715.19 Is BSGM or APT more profitable? Alpha Pro Tech has a net margin of 6.99% compared to BioSig Technologies' net margin of -44,832.50%. Alpha Pro Tech's return on equity of 6.70% beat BioSig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets BioSig Technologies-44,832.50% N/A -776.49% Alpha Pro Tech 6.99%6.70%5.76% Do insiders & institutionals have more ownership in BSGM or APT? 7.2% of BioSig Technologies shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 17.0% of BioSig Technologies shares are held by company insiders. Comparatively, 14.0% of Alpha Pro Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in BSGM or APT? BioSig Technologies received 80 more outperform votes than Alpha Pro Tech when rated by MarketBeat users. However, 100.00% of users gave Alpha Pro Tech an outperform vote while only 70.55% of users gave BioSig Technologies an outperform vote. CompanyUnderperformOutperformBioSig TechnologiesOutperform Votes10370.55% Underperform Votes4329.45% Alpha Pro TechOutperform Votes23100.00% Underperform VotesNo Votes Which has more risk & volatility, BSGM or APT? BioSig Technologies has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of -0.64, meaning that its share price is 164% less volatile than the S&P 500. Does the media prefer BSGM or APT? In the previous week, Alpha Pro Tech had 1 more articles in the media than BioSig Technologies. MarketBeat recorded 1 mentions for Alpha Pro Tech and 0 mentions for BioSig Technologies. BioSig Technologies' average media sentiment score of 0.00 equaled Alpha Pro Tech'saverage media sentiment score. Company Overall Sentiment BioSig Technologies Neutral Alpha Pro Tech Neutral Do analysts prefer BSGM or APT? BioSig Technologies currently has a consensus price target of $2.75, indicating a potential upside of 197.30%. Given BioSig Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe BioSig Technologies is more favorable than Alpha Pro Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAlpha Pro Tech beats BioSig Technologies on 8 of the 15 factors compared between the two stocks. Get BioSig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.22M$3.37B$5.84B$9.15BDividend YieldN/A1.64%4.75%3.85%P/E RatioN/A15.9125.4719.00Price / Sales797.3573.24447.5876.30Price / CashN/A44.0938.0134.83Price / Book-2.803.857.644.62Net Income-$29.04M$92.00M$3.18B$245.85M7 Day Performance-1.60%4.50%-1.99%-2.68%1 Month Performance-18.86%9.09%-0.42%-2.19%1 Year Performance189.79%12.27%16.51%12.84% BioSig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBioSig Technologies1.4969 of 5 stars$0.93+12.1%$2.75+197.3%+156.8%$14.22M$20,000.000.0050High Trading VolumeAPTAlpha Pro TechN/A$5.40-1.5%N/A+4.9%$59.40M$61.23M14.59120TMDIFTitan MedicalN/A$0.50flatN/A+646.3%$56.78M$17.63M-0.4050CTSOCytosorbents2.5225 of 5 stars$0.99-2.9%$4.67+371.3%+15.0%$54.14M$36.35M-2.75220Analyst ForecastAPYXApyx Medical1.4598 of 5 stars$1.43+1.4%N/A-25.2%$53.83M$52.35M-1.72270INOInovio Pharmaceuticals3.2285 of 5 stars$1.92-2.0%$12.40+545.8%-71.6%$50.11M$830,000.00-0.91320News CoverageMODDModular Medical2.8749 of 5 stars$1.20-0.8%$5.00+316.7%-38.4%$48.80MN/A-1.9020Gap UpNXLNexalin Technology1.2018 of 5 stars$3.52-5.4%$3.00-14.8%+794.1%$46.82M$110,000.00-5.503MBOTMicrobot Medical1.8015 of 5 stars$2.31-9.4%$9.00+289.6%+25.4%$46.75MN/A-2.8920High Trading VolumeBLACBellevue Life Sciences AcquisitionN/A$10.93-2.6%N/A-67.4%$44.15MN/A0.00N/AGap DownOMOutset Medical1.7018 of 5 stars$0.79-3.1%$4.50+473.2%-72.7%$42.15M$130.38M-0.28520Earnings ReportNews Coverage Related Companies and Tools Related Companies Alpha Pro Tech Competitors Titan Medical Competitors Cytosorbents Competitors Apyx Medical Competitors Inovio Pharmaceuticals Competitors Modular Medical Competitors Nexalin Technology Competitors Microbot Medical Competitors Bellevue Life Sciences Acquisition Competitors Outset Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BSGM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
